Kineta Announces Exclusivity and Right of First Offer Agreement for VISTA Blocking Antibody with TuHURA Biosciences.
Biotechnology Company Announces Major Agreement For Worldwide Exclusive Rights
Biotechnology Company Announces Major…
Biotechnology Company Announces Major Agreement For Worldwide Exclusive Rights
Kineta Announces Exclusivity and Right of First Offer Agreement for VISTA Blocking Antibody with TuHURA Biosciences.